Sofinnova raises EUR 472m for life science fund

Now is the time to invest in healthcare, says Sofinnova Partners, as it announces a new fund to back life science startups.
Photo: Antonio Bronic/Reuters/Ritzau Scanpix
Photo: Antonio Bronic/Reuters/Ritzau Scanpix
BY ANDREAS LØNSTRUP, TRANSLATED BY DANIEL PEDERSEN

The European venture capital firm Sofinnova, which specializes in life sciences and healthcare, has raised its tenth life science fund for startups in Europe, writes the European business media Sifted.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading